Pharmacoeconomics of spastic cerebral palsy
Cerebral palsy (CP) is one of the most widespread and socially significant neurological diseases that affect both various aspects of physical and psychoverbal development of children since birth and stages of their personal development and adaptation in society. Over the last years there has been an...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2018-02-01
|
| Series: | Регуляторные исследования и экспертиза лекарственных средств |
| Subjects: | |
| Online Access: | https://www.vedomostincesmp.ru/jour/article/view/55 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849395059985743872 |
|---|---|
| author | R. I. Yagudina A. U. Kulikov N. I. Korolyova D. T. Ugrekhelidze |
| author_facet | R. I. Yagudina A. U. Kulikov N. I. Korolyova D. T. Ugrekhelidze |
| author_sort | R. I. Yagudina |
| collection | DOAJ |
| description | Cerebral palsy (CP) is one of the most widespread and socially significant neurological diseases that affect both various aspects of physical and psychoverbal development of children since birth and stages of their personal development and adaptation in society. Over the last years there has been an increase in the number of children with disabilities in Russia, and it should be noted that CP ranks first among neurological disabilities in children. Given the lifetime course of this disease, CP acquires a huge medical and socioeconomic relevance. In particular, it is necessary to use the most efficient medical technologies (from the point of view of both efficacy, safety and costs). Pharmacoeconomic analysis is the most suitable tool for solving these tasks. However, when performing pharmacoeconomic analysis in the field of cerebral palsy, as well as in any other disease area, it is obligatory to take into account certain peculiarities at the planning and implementation stages. The authors of the article have identified specific features of pharmacoeconomic analysis methods based on assessment of health technologies related to cerebral palsy. |
| format | Article |
| id | doaj-art-d4dcdecbbcf04a1fa1ec9b6d81c363e2 |
| institution | Kabale University |
| issn | 3034-3062 3034-3453 |
| language | Russian |
| publishDate | 2018-02-01 |
| publisher | Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) |
| record_format | Article |
| series | Регуляторные исследования и экспертиза лекарственных средств |
| spelling | doaj-art-d4dcdecbbcf04a1fa1ec9b6d81c363e22025-08-20T03:39:45ZrusFederal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)Регуляторные исследования и экспертиза лекарственных средств3034-30623034-34532018-02-0103606453Pharmacoeconomics of spastic cerebral palsyR. I. Yagudina0A. U. Kulikov1N. I. Korolyova2D. T. Ugrekhelidze3Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationI.M. Sechenov First Moscow State Medical UniversityCerebral palsy (CP) is one of the most widespread and socially significant neurological diseases that affect both various aspects of physical and psychoverbal development of children since birth and stages of their personal development and adaptation in society. Over the last years there has been an increase in the number of children with disabilities in Russia, and it should be noted that CP ranks first among neurological disabilities in children. Given the lifetime course of this disease, CP acquires a huge medical and socioeconomic relevance. In particular, it is necessary to use the most efficient medical technologies (from the point of view of both efficacy, safety and costs). Pharmacoeconomic analysis is the most suitable tool for solving these tasks. However, when performing pharmacoeconomic analysis in the field of cerebral palsy, as well as in any other disease area, it is obligatory to take into account certain peculiarities at the planning and implementation stages. The authors of the article have identified specific features of pharmacoeconomic analysis methods based on assessment of health technologies related to cerebral palsy.https://www.vedomostincesmp.ru/jour/article/view/55спастичностьдетский церебральный параличфармакоэкономический анализмоделированиеанализ затратанализ эффективностикритерии эффективностианализ «влияния на бюджет»оценка технологий здравоохраненияspasticitycerebral palsypharmacoeconomic analysismodelingcost analysisefficiency analysisefficiency criteriabudget impact analysishealth technologies assessment |
| spellingShingle | R. I. Yagudina A. U. Kulikov N. I. Korolyova D. T. Ugrekhelidze Pharmacoeconomics of spastic cerebral palsy Регуляторные исследования и экспертиза лекарственных средств спастичность детский церебральный паралич фармакоэкономический анализ моделирование анализ затрат анализ эффективности критерии эффективности анализ «влияния на бюджет» оценка технологий здравоохранения spasticity cerebral palsy pharmacoeconomic analysis modeling cost analysis efficiency analysis efficiency criteria budget impact analysis health technologies assessment |
| title | Pharmacoeconomics of spastic cerebral palsy |
| title_full | Pharmacoeconomics of spastic cerebral palsy |
| title_fullStr | Pharmacoeconomics of spastic cerebral palsy |
| title_full_unstemmed | Pharmacoeconomics of spastic cerebral palsy |
| title_short | Pharmacoeconomics of spastic cerebral palsy |
| title_sort | pharmacoeconomics of spastic cerebral palsy |
| topic | спастичность детский церебральный паралич фармакоэкономический анализ моделирование анализ затрат анализ эффективности критерии эффективности анализ «влияния на бюджет» оценка технологий здравоохранения spasticity cerebral palsy pharmacoeconomic analysis modeling cost analysis efficiency analysis efficiency criteria budget impact analysis health technologies assessment |
| url | https://www.vedomostincesmp.ru/jour/article/view/55 |
| work_keys_str_mv | AT riyagudina pharmacoeconomicsofspasticcerebralpalsy AT aukulikov pharmacoeconomicsofspasticcerebralpalsy AT nikorolyova pharmacoeconomicsofspasticcerebralpalsy AT dtugrekhelidze pharmacoeconomicsofspasticcerebralpalsy |